SightfileU.S. market data from official filings

Companies › WGS

GENEDX HOLDINGS CORP COM CL A (WGS)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001818331 · EDGAR filings · Updated 2026-07-28

GENEDX HOLDINGS CORP COM CL A (WGS) has reported institutional ownership of 105.3%, with 241 institutional managers holding positions valued at $2.01B per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).

Institutional ownership
105.3%
Institutional managers
241
Reported 13F value
$2.01B
Insider activity
241 trans.
−$77.1M net selling
Data flags
2 active
from SEC filings

Filings this week (1)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, GENEDX HOLDINGS CORP COM CL A has 241 institutional holders and institutional ownership of 105.3%.

Insider activity

Insiders reported 241 transactions (15 buys, 163 sells) across 10 reporting insiders, with a net reported value of −$77.1M.

Data flags from SEC filings

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2022-12-30 (recurring since 2022-12-30) — source filing. The authoritative details are those stated in the filing itself.
Active non-reliance notice on previously issued financial statements (8-K Item 4.02), most recently filed 2022-03-14 (recurring since 2021-05-05) — source filing. The authoritative details are those stated in the filing itself.

Related companies

AGIOS PHARMACEUTICALS INC (AGIO) · ADAPTIVE BIOTECHNOLOGIES COR (ADPT) · ULTRAGENYX PHARMACEUTICAL IN (RARE) · AMNEAL PHARMACEUTICALS INC (AMRX) · NEKTAR THERAPEUTICS (NKTR) · ADMA BIOLOGICS (ADMA)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.